NASDAQ$OPCH

Option Care Health, Inc · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Briefing

Announced financial results, demonstrating substantial revenue growth and improved profitability.

Option Care Health reported a strong first quarter in 2022, with a 20.6% increase in net revenue, a significant rise in gross profit, and a shift from net loss to net income. The company's adjusted EBITDA also saw a substantial increase, and cash flow from operations improved significantly.

  • Net revenue increased by 20.6% to $915.8 million compared to the first quarter of 2021.
  • Gross profit rose by 21.4% to $200.9 million, representing 21.9% of net revenue.
  • Net income was $30.3 million, or $0.17 per share, a significant improvement from the net loss in the same period last year.
  • Adjusted EBITDA increased by 48.9% to $77.8 million.

Headline financials

Total Revenue

$916M

Previous: $759M+20.6%
EPS (adj)

$0.17

Previous: -$0.02+950.0%
Adjusted EBITDA

$77.8M

Previous: $52.2M+48.9%
Capital Expenditures

-$5.36M

Previous: -$3.12M-71.6%
Free Cash Flow

$24.9M

Previous: -$5.98M+516.4%
Net Income

$30.3M

Previous: -$2.86M+1158.2%
Operating Income

$52.2M

Previous: $29.1M+79.6%
Gross Profit

$201M

Previous: $165M+21.4%
Cash & Equivalents

$146M

Previous: $109M+33.1%
Total Assets

$2.88B

Previous: $2.64B+9.0%
Stock-Based Comp

$4.18M

Previous: $1.21M+246.7%

Revenue & EPS history

Option Care Health · Revenue · Quarterly

$916M

Q1 2022+20.6%vs Q1 2021
Beat estimate in 10 of 16 quarters(63%)
ActualEstimate

Forward guidance

For the full year 2022, Option Care Health expects to generate net revenue between $3.75 billion and $3.90 billion, adjusted EBITDA between $320 million and $335 million, and cash flow from operations of at least $230 million.

Tailwinds

  • Net Revenue of $3.75 billion to $3.90 billion
  • Adjusted EBITDA of $320 million to $335 million
  • Cash Flow from Operations of at least $230 million
  • Overall, the company expects 2022 to be a productive year.
  • The Option Care Health team executed exceptionally to ensure high quality patient care and solid financial results.

Headwinds

  • Ongoing pandemic disruption
  • Challenging environment
  • Uncertainty regarding material reconciling items for Adjusted EBITDA guidance.
  • Changes in laws and regulations applicable to the business model
  • Changes in market conditions and receptivity to services and offerings.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

-1.9%

Avg return

Earnings day

-4.2%

Avg return

5 days after

-1.9%

Avg return

30 days after

50%

36 / 72 earnings

Positive

+27.4%

Q3 2015

Best reaction

-53.6%

Q3 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-24.3%-20.7%-22.4%
Q4 2025-7.3%-10.1%-23.1%
Q3 2025-8.7%-5.7%+8.5%
Q1 2025-6.9%-0.1%-2.2%
Q4 2024+1.6%+4.1%+6.4%
Q3 2024-24.5%-26.3%-22.0%
Q2 2024-1.9%-5.3%+2.1%
Q1 2024-1.6%-2.6%-6.0%
Q4 2023-3.4%-1.8%-2.0%
Q3 2023-15.6%-18.4%-8.1%
Q2 2023+5.3%+4.0%+7.9%
Q1 2023-14.7%-12.6%-11.4%
Q4 2022+7.1%+6.3%+9.4%
Q3 2022-10.9%-13.3%-17.6%
Q2 2022+5.0%+4.8%-2.2%
Q1 2022+10.3%+7.4%+14.2%
Q4 2021+8.6%+10.8%+20.9%
Q3 2021-0.0%-2.1%-12.1%
Q2 2021-0.1%+8.3%+35.1%
Q1 2021-4.7%-8.8%+2.3%
Q4 2020+2.2%+1.9%-3.7%
Q3 2020+11.4%+11.7%+14.1%
Q2 2020+3.6%+1.7%-2.8%
Q1 2020+8.8%+6.6%+32.7%
Q4 2019-12.8%-16.1%-48.4%
Q3 2019-2.4%-5.9%-16.3%
Q2 2019-1.4%-5.2%+21.5%
Q1 2019-2.5%-1.5%-4.0%
Q4 2018-33.0%-38.7%-50.4%
Q3 2018+16.0%+12.8%+34.2%
Q2 2018-1.5%+2.5%+4.4%
Q1 2018-6.1%-0.4%+6.9%
Q4 2017+3.3%+0.0%+9.8%
Q3 2017-13.8%-18.8%+5.8%
Q2 2017+8.6%+21.8%+6.8%
Q1 2017+3.6%+1.8%+24.2%
Q4 2016-12.3%-10.6%-33.9%
Q3 2016-53.6%-47.9%-56.3%
Q2 2016+3.0%+2.6%+2.3%
Q1 2016+3.1%
Q4 2015+7.1%
Q3 2015+27.4%
Q2 2015-22.8%
Q1 2015-10.0%
Q4 2014-11.3%
Q3 2014+1.3%
Q2 2014-4.4%
Q1 2014+2.1%
Q4 2013+6.3%
Q2 1997+9.0%
Q3 2013-4.6%
Q2 2013-17.2%
Q1 2013-0.1%
Q4 2012-1.5%
Q3 2012+3.7%
Q2 2012+11.0%
Q1 2012+3.2%
Q4 2011-1.5%
Q3 2011-11.2%
Q2 2011+1.5%
Q4 2010+1.5%
Q1 2011-1.4%
Q3 2010+8.1%
Q2 2010-3.0%
Q1 2009+0.9%
Q1 2010+3.4%
Q2 2009+2.6%
Q4 2007+2.6%
Q4 2009+2.6%
Q3 2009+5.6%
Q3 2008+5.6%
Q4 2008+5.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro